The Blumberg Institute and Hepatitis B Foundation mourn the passing of John C. Martin, pharmaceutical industry leader. <<click here>>

Blumberg Prize for 2021 awarded to Dr. Wenhui Li

The Hepatitis B Foundation announced on Nov. 12 that Wenhui Li, Ph.D., has been chosen as the recipient of its 2021 Baruch S. Blumberg Prize for outstanding contributions to advance the science and medicine of hepatitis B.

An investigator at China‚Äôs National Institute of Biological Sciences (NIBS), Dr. Li is being recognized for his discovery of the hepatitis B virus (HBV) receptor on hepatocytes, a breakthrough that will have a major influence on the future of therapeutics for people living with chronic hepatitis B infections. Please read more here.